HealthLeaders Media September 27, 2018
The arrangement aims to advance, and is contingent upon, regulatory review of the CVS-Aetna merger.
KEY TAKEAWAYS
Stakeholders had raised concerns that the CVS-Aetna deal could reduce competition among Part D plans.
Aetna plans to transfer its Part D business to WellCare at the end of the year, but Aetna will retain financial risk and administrative duties.
All of this is contingent upon regulatory review by state and federal authorities.
When the clock strikes midnight on New Year’s Eve, ownership of Aetna’s standalone Medicare Part D prescription drug plans will transfer to WellCare Health Plans under the terms of an agreement disclosed Thursday morning to federal regulators.
Aetna is shedding its Part D business...
Today's Sponsors
Today's Sponsor